Prospects for the development of methods of predicting safe substance levels based on "structure-activity" relationships
Krasovskiĭ, G.N.; Egorova, N.A.
Vestnik Akademii Meditsinskikh Nauk SSSR 7: 88-95
1980
ISSN/ISBN: 0002-3027 PMID: 6998177 Document Number: 165572
Document emailed within 1 workday
Related Documents
Rosenkranz, H.S.; Frierson, M.R.; Klopman, G. 1986: Use of structure-activity relationships in predicting carcinogenesis Iarc Scientific Publications 1986(83): 497-517Rejholec, V.; Kuchar, M. 1980: Use of methods of differentiating between arrangements in chemical structure and biological activity relationships Ceskoslovenska Farmacie 29(8-9): 315-320
Adams, G.E.; Clarke, E.D.; Flockhart, I.R.; Jacobs, R.S.; Sehmi, D.S.; Stratford, I.J.; Wardman, P.; Watts, M.E.; Parrick, J.; Wallace, R.G.; Smithen, C.E. 1979: Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine 35(2): 133-150
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Richards, R.K. 1980: Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity Archives Internationales de Pharmacodynamie et de Therapie 244(1): 107-112
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Bercher, H.; Grisk, A. 1976: Structure-activity relationships of halogenated phenylethanolamine and phenoxypropanolamine Acta Biologica et Medica Germanica 35(1): 79-85
Beránek, J. 1986: A study on structure-activity relationships of nucleoside analogues Drugs under Experimental and Clinical Research 12(4): 355-367
Mager, P.P. 1983: Structure-activity relationships of dermorphin tetrapeptide amides Die Pharmazie 38(8): 563
Bowden, K.; Harris, N.V.; Watson, C.A. 1993: Structure-activity relationships of dihydrofolate reductase inhibitors Journal of ChemoTherapy 5(6): 377-388
Barth, A.; Franke, R. 1975: Quantitative structure-activity relationships in phytotoxic piperidinoacetanilides Environmental Quality and Safety. Supplement 3: 467-472
Rietschel, E.T.; Seydel, U.; Zähringer, U.; Schade, U.F.; Brade, L.; Loppnow, H.; Feist, W.; Wang, M.H.; Ulmer, A.J.; Flad, H.D. 1991: Bacterial endotoxin: molecular relationships between structure and activity Infectious Disease Clinics of North America 5(4): 753-779
Lattrell, R.; Dürckheimer, W.; Kirrstetter, R.; Limbert, M.; Seibert, G. 1987: Structure-activity relationships in the cefpirome (HR 810) series: synthesis and antibacterial activity of 7 alpha-methoxy and 7 alpha-formylamino analogues of HR 810 Chemioterapia: international journal of the Mediterranean Society of Chemotherapy 6(2 Suppl): 96-97
Ebert, B.; Madsen, U.; Johansen, T.N.; Krogsgaard-Larsen, P. 1991: NMDA receptor agonists: relationships between structure and biological activity Advances in Experimental Medicine and Biology 287: 483-487
Francia, E.; Marin, A.; Verdejo, F.; Sanchez, M.S.; Morell, J. 1975: New oral antidiabetic drugs. Synthesis and structure-activity relationships Bollettino Chimico Farmaceutico 114(7): 379-392